The characteristics of population structure and antimicrobial resistance of Streptococcus suis serotype 8, a non-negligible pathotype

Transbound Emerg Dis. 2022 Sep;69(5):e2495-e2505. doi: 10.1111/tbed.14592. Epub 2022 May 24.

Abstract

Streptococcus suis, the leading causative agent of swine streptococcosis, is considered as a severe zoonotic and foodborne pathogen for humans. Characteristics of population structure and pathogenicity of S. suis vary significantly by serotypes. As one of the main pathogenic serotypes causing clinical disease in pigs, very little is known about the pathogenicity, population structure, and antimicrobial resistance of S. suis serotype 8 (SS8). In this study, the genome of 26 SS8 strains isolated from healthy and diseased pigs was sequenced. Together with 38 sequences from NCBI, we found that SS8 population was clustered into 12 sequence types (ST) and 4 minimum core genome (MCG) groups, linked to the geographical distribution. Noteworthily, 10 strains belonged to MCG group 1 which was defined to possess the capacity to cause global outbreaks in our previous study. We found that 75% (9/12) of representative SS8 strains were virulent in mice and zebrafish, including all ST1241 strains. No virulence indicators were identified from 67 putative virulence-associated genes mainly identified among pathogenic serotype 2 strains. Instead, we found that the genotype of some of these genes was correlated to their evolution. All 26 isolates were classified as multidrug-resistant strains by antimicrobial susceptibility testing. The high carrying rate of tetO and ermB, mainly disseminated by integrative mobilizable elements, contributed to the prevalent resistance phenotypes to macrolides, lincosamides and tetracyclines. These findings indicated that the pathogenic potential of SS8 cannot be ignored and provided valuable information for SS8 surveillance.

Keywords: Streptococcus suis serotype 8; antimicrobial resistance; pathogenicity; population structure.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial / genetics
  • Humans
  • Lincosamides
  • Macrolides
  • Mice
  • Serogroup
  • Streptococcal Infections* / epidemiology
  • Streptococcal Infections* / veterinary
  • Streptococcus suis* / genetics
  • Swine
  • Swine Diseases* / epidemiology
  • Tetracyclines
  • Zebrafish

Substances

  • Anti-Bacterial Agents
  • Lincosamides
  • Macrolides
  • Tetracyclines